2026 Global: Cardiac Mri And Ct Software Market -Competitive Review (2032) report
Description
The 2026 Global: Cardiac Mri And Ct Software Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac mri and ct software market by geography and historical trend. The scope of the report extends to sizing of the cardiac mri and ct software market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V. lead the Cardiac MRI and CT Software Market, followed by Canon Medical Systems, FUJIFILM Holdings, and specialized firms like Circle Cardiovascular Imaging. These ten major companies dominate through innovative AI-driven solutions for cardiac image analysis, 3D reconstruction, and workflow optimization across MRI and CT modalities. Siemens Healthineers, with USD 20.63 billion in annual revenue, offers advanced cardiac MRI scanners like the MAGNETOM Sola and integrated software for precise diagnostics. GE Healthcare, at USD 19.55 billion revenue, provides Centricity Cardio Enterprise and CardioGraphe for high-resolution CT imaging, enhanced by AI for echocardiography and digital integration. Koninklijke Philips N.V. excels in AI-enabled ultrasound and multi-modality platforms, automating measurements for echocardiography labs as seen in their June 2024 releases. Canon Medical Systems, boasting USD 30.04 billion revenue, delivers CT and MRI software for cardiovascular treatment planning, bolstered by research collaborations. FUJIFILM Holdings advances diagnostic imaging with CT and MRI systems tailored for cardiac applications, supporting preventive cardiology.
Specialized providers like Circle Cardiovascular Imaging and Pie Medical Imaging focus on vendor-neutral, AI-powered tools for Cardiac MRI and CT. Circle CVI's cvi42 platform supports multi-modality analysis including cardiac MR, CT, and plaque quantification, trusted in over 50 countries with 2024 AI upgrades. Pie Medical Imaging offers quantitative X-ray, CT, and MR solutions for coronary and ventricular analysis, emphasizing vendor independence and over 30 years of innovation. NeoSoft LLC's suiteHEART enables zero-click AI preprocessing for MRI function, flow, and mapping, prioritizing accessibility without upgrade fees. Arterys pioneers cloud-based AI for MRI and CT scans, with FDA clearance and partnerships enhancing automation in cardiovascular care, despite smaller USD 25 million revenue. Symphony Innovation, LLC, at USD 5 billion revenue, deploys FDA-approved algorithms for MRI, CT, and echocardiogram precision, optimizing workflows via strategic expansions.
Medis Medical Imaging rounds out the top ten with robust post-processing for CT, MRI, and hybrid modalities. Medis Suite CT and XA provide fast, reproducible quantitative analysis for TAVI risk stratification and coronary evaluations, vendor-independent for clinical and research use. These leaders drive market growth from USD 0.71 billion in 2024 to USD 1.73 billion by 2035, fueled by AI integration, non-invasive techniques, and partnerships like GE-MedIs for QFR on Allia platforms. North America holds the largest share due to CVD prevalence and tech investments, with firms innovating in multi-modality support and personalized medicine.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac mri and ct software market by geography and historical trend. The scope of the report extends to sizing of the cardiac mri and ct software market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V. lead the Cardiac MRI and CT Software Market, followed by Canon Medical Systems, FUJIFILM Holdings, and specialized firms like Circle Cardiovascular Imaging. These ten major companies dominate through innovative AI-driven solutions for cardiac image analysis, 3D reconstruction, and workflow optimization across MRI and CT modalities. Siemens Healthineers, with USD 20.63 billion in annual revenue, offers advanced cardiac MRI scanners like the MAGNETOM Sola and integrated software for precise diagnostics. GE Healthcare, at USD 19.55 billion revenue, provides Centricity Cardio Enterprise and CardioGraphe for high-resolution CT imaging, enhanced by AI for echocardiography and digital integration. Koninklijke Philips N.V. excels in AI-enabled ultrasound and multi-modality platforms, automating measurements for echocardiography labs as seen in their June 2024 releases. Canon Medical Systems, boasting USD 30.04 billion revenue, delivers CT and MRI software for cardiovascular treatment planning, bolstered by research collaborations. FUJIFILM Holdings advances diagnostic imaging with CT and MRI systems tailored for cardiac applications, supporting preventive cardiology.
Specialized providers like Circle Cardiovascular Imaging and Pie Medical Imaging focus on vendor-neutral, AI-powered tools for Cardiac MRI and CT. Circle CVI's cvi42 platform supports multi-modality analysis including cardiac MR, CT, and plaque quantification, trusted in over 50 countries with 2024 AI upgrades. Pie Medical Imaging offers quantitative X-ray, CT, and MR solutions for coronary and ventricular analysis, emphasizing vendor independence and over 30 years of innovation. NeoSoft LLC's suiteHEART enables zero-click AI preprocessing for MRI function, flow, and mapping, prioritizing accessibility without upgrade fees. Arterys pioneers cloud-based AI for MRI and CT scans, with FDA clearance and partnerships enhancing automation in cardiovascular care, despite smaller USD 25 million revenue. Symphony Innovation, LLC, at USD 5 billion revenue, deploys FDA-approved algorithms for MRI, CT, and echocardiogram precision, optimizing workflows via strategic expansions.
Medis Medical Imaging rounds out the top ten with robust post-processing for CT, MRI, and hybrid modalities. Medis Suite CT and XA provide fast, reproducible quantitative analysis for TAVI risk stratification and coronary evaluations, vendor-independent for clinical and research use. These leaders drive market growth from USD 0.71 billion in 2024 to USD 1.73 billion by 2035, fueled by AI integration, non-invasive techniques, and partnerships like GE-MedIs for QFR on Allia platforms. North America holds the largest share due to CVD prevalence and tech investments, with firms innovating in multi-modality support and personalized medicine.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.